Oral antithrombotic use among myocardial infarction patientsVAN DER ELST, Menno E; CISNEROS-GONZALEZ, Nelly; DE BLAEY, Cornelis J et al.The Annals of pharmacotherapy. 2003, Vol 37, Num 1, pp 143-146, issn 1060-0280, 4 p.Article

Pharmacogenetics of oral anticoagulantsDALY, Ann K; KING, Barry P.Pharmacogenetics (London). 2003, Vol 13, Num 5, pp 247-252, issn 0960-314X, 6 p.Article

Subtherapeutic oral anticoagulant therapy : Frequency and risk factorsROMBOUTS, Eva K; ROSENDAAL, Frits R; VAN DER MEER, Felix J. M et al.Thrombosis and haemostasis. 2009, Vol 101, Num 3, pp 552-556, issn 0340-6245, 5 p.Article

Influenza vaccination in patients on long-term anticoagulant therapyIORIO, A. M; CAMILLONI, B; BASILEO, M et al.Vaccine. 2006, Vol 24, Num 44-46, pp 6624-6628, issn 0264-410X, 5 p.Article

Pharmacogenetics of oral anticoagulantsROJAS, Julio César; AGUILAR, Bernardo; RODRIGUEZ-MALDONADO, Emma et al.Blood coagulation & fibrinolysis. 2005, Vol 16, Num 6, pp 389-398, issn 0957-5235, 10 p.Article

Model predictive control for optimal oral anticoagulant drug administrationPANNOCCHIA, Gabriele; BRAMBILLA, Alessandro.AIChE journal. 2006, Vol 52, Num 9, pp 3315-3320, issn 0001-1541, 6 p.Article

The optimal management of patients on oral anticoagulation undergoing coronary artery stenting: The 10^th Anniversary OverviewRUBBOLI, Andrea; FAXON, David P; JUHANI AIRAKSINEN, K. E et al.Thrombosis and haemostasis. 2014, Vol 112, Num 6, pp 1080-1087, issn 0340-6245, 8 p.Article

New oral anticoagulants in venous thromboembolism prophylaxis in orthopaedic patients: Are they really better?HUO, Michael H.Thrombosis and haemostasis. 2011, Vol 106, Num 1, pp 45-57, issn 0340-6245, 13 p.Article

Point-of-care (POCT) prothrombin time monitors : is a periodical control of their performance useful?BARCELLONA, Doris; FENU, Lara; CORNACCHINI, Simona et al.Thrombosis research. 2009, Vol 123, Num 5, pp 775-779, issn 0049-3848, 5 p.Article

Differential inhibition of thrombin generation by vitamin K antagonists alone and associated with Iow-molecular-weight heparinGEROTZIAFAS, Grigoris T; DUPONT, Charlotte; SPYROPOULOS, Alex C et al.Thrombosis and haemostasis. 2009, Vol 102, Num 1, pp 42-48, issn 0340-6245, 7 p.Article

Overview of Direct Thrombin Inhibitors in Clinical PracticeBOUNAMEAUX, Henri.Seminars in thrombosis and hemostasis. 2008, Vol 34, pp 12-17, issn 0094-6176, 6 p., SUP1Article

Oral-anticoagulant-related intracerebral hemorrhagePUNTHAKEE, Xerxes; DOOBAY, Jaya; ANAND, Sonia S et al.Thrombosis research. 2002, Vol 108, Num 1, pp 31-36, issn 0049-3848, 6 p.Article

Usefulness of a second temporary vena cava filter for preventing acute pulmonary thromboembolismISHIKAWA, Tetsuya; OKABE, Teruo; OGAWA, Kazuo et al.Circulation journal. 2003, Vol 67, Num 8, pp 718-720, issn 1346-9843, 3 p.Article

Ultrasound bone mass in patients undergoing chronic therapy with oral anticoagulantsREY-SANCHEZ, Purificacion; LAVADO-GARCIA, Jesus Maria; CANAL-MACIAS, Maria Luz et al.Journal of bone and mineral metabolism (English ed.). 2011, Vol 29, Num 5, pp 546-551, issn 0914-8779, 6 p.Article

Combination warfarin-ASA therapy: Which patients should receive it, which patients should not, and why?DOUKETIS, James D.Thrombosis research. 2011, Vol 127, Num 6, pp 513-517, issn 0049-3848, 5 p.Article

The frequency of cytochrome P450 2C9 genetic variants in the Russian population and their associations with individual sensitivity to warfarin therapyPCHELINA, Sofya N; SIROTKINA, Olga V; TARASKINA, Anastasiya E et al.Thrombosis research. 2005, Vol 115, Num 3, pp 199-203, issn 0049-3848, 5 p.Article

A prospective controlled study of a computer-assisted acenocoumarol dosage programMARCO, Fernando; SEDANO, Carmen; BERMUDEZ, Arancha et al.Pathophysiology of haemostasis and thrombosis (Print). 2003, Vol 33, Num 2, pp 59-63, issn 1424-8832, 5 p.Article

Implementation of SintromacWeb®, a new internet-based tool for oral anticoagulation therapy telecontrol: Study on system consistency and patient satisfactionFERRANDO, Fernando; MIRA, Yolanda; CONTRERAS, Maria Teresa et al.Thrombosis and haemostasis. 2010, Vol 103, Num 5, pp 1091-1101, issn 0340-6245, 11 p.Article

Efficacy and safety of a prothrombin complex concentrate (Octaplex®) for rapid reversal of oral anticoagulationLUBETSKY, Aaron; HOFFMAN, Ron; ZIMLICHMAN, Reuven et al.Thrombosis research. 2004, Vol 113, Num 6, pp 371-378, issn 0049-3848, 8 p.Article

Point of care monitors for oral anticoagulant therapyNUTESCU, Edith A.Seminars in thrombosis and hemostasis. 2004, Vol 30, Num 6, pp 697-702, issn 0094-6176, 6 p.Conference Paper

Effects of lepirudin, argatroban and melagatran and additional influence of phenprocoumon on ecarin clotting timeFENYVESI, Tivadar; JÖRG, Ingrid; WEISS, Christel et al.Thrombosis research. 2003, Vol 111, Num 1-2, pp 89-94, issn 0049-3848, 6 p.Article

Over-the-counter vitamin K₁-containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K₁-depleted patients: A prospective, controlled trialKURNIK, Daniel; LOEBSTEIN, Ronen; RABINOVITZ, Hadas et al.Thrombosis and haemostasis. 2004, Vol 92, Num 5, pp 1018-1024, issn 0340-6245, 7 p.Article

Matrix Gla-protein : The calcification inhibitor in need of vitamin K : Vitamin K-dependent proteins: Functions in blood coagulation and beyondSCHURGERS, Leon J; CRANENBURG, Ellen C. M; VERMEER, Cees et al.Thrombosis and haemostasis. 2008, Vol 100, Num 4, pp 593-603, issn 0340-6245, 11 p.Article

Vitamin K : The coagulation vitamin that became omnipotentCRANEHBURG, Ellen C. M; SCHURGERS, Leon J; VERMEER, Cees et al.Thrombosis and haemostasis. 2007, Vol 98, Num 1, pp 120-125, issn 0340-6245, 6 p.Article

Fucosylated chondroitin sulfate as a new oral antithrombotic agentFONSECA, Roberto J. C; MOURAO, Paulo A. S.Thrombosis and haemostasis. 2006, Vol 96, Num 6, pp 822-829, issn 0340-6245, 8 p.Article